
The Invesco Golden Dragon China ETF (PGJ) is designed to mirror the performance of the NASDAQ Golden Dragon China Index. To achieve this objective, the fund typically allocates a minimum of 90% of its total assets to the shares of companies included in that index. The NASDAQ Golden Dragon China Index, in turn, comprises companies listed on US stock exchanges that are either headquartered or legally established in the People's Republic of China, or generate the vast majority of their income from that country. Both the ETF's portfolio and its underlying benchmark index undergo quarterly adjustments and updates.
Is PGJ's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

China's industrial profit surge puts the spotlight on ETFs like CQQQ as deflation ends and high-tech growth drives resilience amid global turmoil.

Nio stock climbs on impressive Q1 delivery results. See the latest technical analysis, price targets, and analyst ratings for 2026.

The Invesco Golden Dragon China ETF targets only US-listed Chinese stocks, offering liquidity and transparency but exposing investors to lagged market reactions and potential delisting risks. We elaborate on how PGJ comes across as inferior to the more popular MCHI. With weak consumer conditions (50% of this portfolio is exposed to the discretionary sector), unappealing valuations, and lack of technical momentum, PGJ is not a buy.

The Invesco Golden Dragon China ETF stands out right with its over 20% returns YTD, ahead of the Shanghai Composite and the S&P 500. Despite this, it's hard to fully get behind the PGJ story right now, as tariff flip-flops between the U.S. and China create uncertainty. Additionally, the Chinese economy continues to struggle, which can cast a shadow on the impressive growth in the technology sector.

As the U.S. wrestles China for AI dominance, investors are playing both sides.